Follow us on Twitter
twitter icon@FreshPatents


Skin patents

      

This page is updated frequently with new Skin-related patent applications.




 Hybrid mobile interactions for native apps and web apps patent thumbnailHybrid mobile interactions for native apps and web apps
There is disclosed a system, including apparatus, methods and computer programs, for running native software applications (apps) and html5 web-based apps on a computing device, particularly a mobile computing device, in a multitasking mode of operation. In one embodiment, touch screen displays having one or more browsers are adapted to run one or more html5 apps, and receive input from hand gestures.
Intel Corporation


 General-purpose reconfigurable conduit and reaction chamber microfluidic arrangements for lab-on-chip and miniature chemical processing patent thumbnailGeneral-purpose reconfigurable conduit and reaction chamber microfluidic arrangements for lab-on-chip and miniature chemical processing
A general-purpose software-reconfigurable chemical process system useful in a wide range of applications is disclosed. Embodiments may include software control of internal processes, automated provisions for cleaning internal elements with solvents, provisions for clearing and drying gasses, and multitasking operation.

 Methods, compositions and apparatuses for treating psoriasis by phototherapy patent thumbnailMethods, compositions and apparatuses for treating psoriasis by phototherapy
Compositions, methods and apparatuses for phototherapy to treat skin disorders. In particular, described herein are methods, compositions, phototherapy dressings for use with phototherapy uv light applicators (sources) and phototherapy uv light applicators to treat skin disorders such as psoriasis..

 Devices and methods for treating the skin using a porous member patent thumbnailDevices and methods for treating the skin using a porous member
According to some embodiments, a skin treatment assembly comprises a tip comprising a proximal end and a distal end, a container configured to secure to the tip along the proximal end of the tip, wherein the container is configured to contain a liquid, and a porous member configured to extend at least partially within an interior of the container such that it contact a liquid contained within the container, wherein the porous member is configured to extend at least partially within an interior of the tip and is configured to facilitate the transfer of liquid from the container to the distal end of the tip.. .
Edge Systems Llc


 Hydrogels for treating and ameliorating wounds and methods for making and using them patent thumbnailHydrogels for treating and ameliorating wounds and methods for making and using them
In alternative embodiments, provided are compositions, e.g., pharmaceutical compositions, formulations, kits and other products of manufacture, comprising a hydrogel and active ingredients, including mixed thickness skin micrografts, or full or split-thickness skin grafts, contained or mixed in or within the hydrogel; and methods for making and using them. In alternative embodiments, compositions and methods as provided herein are used for the treatment or amelioration of wounds and surgical sites, and include compositions and methods for micrografting, or for micrografting a wound, or for micrografting a wound for rapid re-epithelialization, or for micrografting a wound for rapid re-epithelialization of large non-healing wounds..
Vicus Therapeutics, Llc


 Phospholipid-containing marine extracts for treatment of cardiovascular diseases patent thumbnailPhospholipid-containing marine extracts for treatment of cardiovascular diseases
The present invention relates to a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport enhancement. The method comprises the administration of a therapeutically effective amount of krill and/or marine oil to a patient.
Neptune Technologies & Bioressources, Inc.


 Method for avoiding or inhibition of dyskinesia patent thumbnailMethod for avoiding or inhibition of dyskinesia
Certain neurological disorders are treated with dopamine agonists (e.g. L-dopa) but these treatments unintentionally cause levodopa-induced dyskinesias (lids) or tardive dyskinesia.
Research Foundation Of The City University Of New York


 Compositions for nail and skin treatment patent thumbnailCompositions for nail and skin treatment
Novel topical compositions for the treatment of nail and skin afflictions comprising at least one active agent, at least one volatile solvent, at least one film-forming ingredient and at least one phospholipid, processes for their preparation and methods of treatment of nail and skin afflictions. Following application of the compositions and evaporation of volatile solvents, the composition produces a film, which has web-like structures containing the active agent(s)..
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd


 Protective skin compositions patent thumbnailProtective skin compositions
The subject of the present invention is cosmetic or pharmaceutical compositions which are protective against common skin irritants or allergens. The invention is also directed to the use of these compositions to protect skin from the effects of metal.
Amantin Experts


 Methods for preparing a skin graft patent thumbnailMethods for preparing a skin graft
The present invention generally relates to methods for applying a skin graft. Methods of the invention involve harvesting an epidermal skin graft, and applying the epidermal skin graft to a recipient site such that the basal layer of the skin graft makes direct contact with the recipient site..
Kci Licensing, Inc.


Optical transfer diagnosis for detection and monitoring of tissue disorders

Systems and methods for discriminating between malignant and benign pigmented skin lesions based on optical analysis using spatial distribution maps, morphological parameters, and additional diagnostic parameters derived from images of tissue lesions. A handheld optical transfer diagnosis device is disclosed capable of capturing a series of reflectance images of a skin lesion at a variety of angles of illumination and observation..
Balter, Inc.

Method and electronic displaying reference locations for locating ecg pads and recording medium using the method

A method and an electronic apparatus for displaying reference locations for locating ecg pads and a recording medium using the method are provided. In the method, a body image is retrieved and a skin area in accordance with a skin color in the body image is detected.
Htc Corporation

N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and n-(4- hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted n-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as hmc compounds) that are useful, for example, in the treatment of disorders (e.g., diseases) including, inflammation and/or joint destruction and/or bone loss; disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; inflammatory and autoimmune disorders, for example, rheumatoid arthritis; psoriasis; psoriatic arthritis; chronic obstructive pulmonary disease (copd); asthma; atherosclerosis; inflammatory bowel disease; ankylosing spondylitis; multiple sclerosis; systemic lupus erythematosus; sjogren's syndrome; a disorder associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, or paget's disease; cancer, such as a haematological malignancy, such as multiple myeloma, leukemia, or lymphoma, or a solid tumour cancer, such as bladder cancer, breast cancer (female and/or male), colon cancer, renal cell carcinoma, kidney cancer, lung cancer, pancreatic cancer, gastric cancer, prostate cancer, brain cancer, skin cancer, thyroid cancer, basal cell ameloblastoma, or melanoma; a disorder associated with fibrosis, such as systemic sclerosis or scleroderma; or a rare vasculitide, such as behçet's disease.
Pimco 2664 Limited

Skin treatment device

The present invention is concerned with a skin treatment device, in particular a temporal hair removal device, having a light emission unit having a substrate, a plurality of first led dies mounted on the substrate on an area of at least 0.2 cm2, in particular of at least 1.0 cm2, where the first led dies are each arranged for emitting light at a first peak emission wavelength in the far red or infrared wavelength range of between 700 nm and 980 nm, and at least one second led die arranged for emitting light at a second peak emission wavelength in the visible wavelength range of between 400 nm and below 700 nm, wherein the skin treatment device is arranged to activate the first led dies to emit a treatment light pulse, the treatment light pulse in particular having a pulse length of between 10 ms and 300 ms, and the first led dies have a radiant flux such that a radiant fluence on the skin of a user of at least 1 j/cm2 is achieved by application of the treatment light pulse, and the skin treatment device is arranged to activate the at least one second led die to emit a visible light pulse simultaneously with the emission of the treatment light pulse.. .
Braun Gmbh

Fenestrated bone wrap graft

The present invention relates to a fenestrated bone wrap graft and a method of preparing cortical bone in thin sheets then fully demineralizing it to give it formed flexibility and then creating fenestrations in the cortical bone in a fashion similar to, but not identical to, skin grafts.. .
Vivex Biomedical, Inc.

Aldose reductase inhibitors and uses thereof

The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like..
The Trustees Of Columbia University In The City Of New York

Aldose reductase inhibitors and uses thereof

The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like..
The Trustees Of Columbia University In The City Of New York

Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

Wherein each of b1, b2, and b3 is independently hydrogen, hydroxy, or alkoxy; and each of b4 and b5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat inflammatory skin disorders and the symptoms associated therewith.. .

Skin compositions and uses

The present invention provides a skin care composition for maintaining or improving the healthy appearance of the skin of an individual and/or rejuvenate the skin of an individual. A skin care composition comprises active ingredients, including, without limitation, growth factors, anti-oxidants, curcuminoids, oils and/or red rice extracts.
Stemetrix, Inc.

Skin treatment device

The present invention is concerned with a skin treatment device, in particular a hair removal device, having a light emission unit comprising a substrate and a plurality of first led dies mounted on the substrate on an area of at least 0.2 cm2, in particular of at least 1 cm2, wherein the skin treatment device is arranged to activate the first led dies to emit a treatment light pulse having a pulse length in particular in the range of between 10 ms and 300 ms and the first led dies have a radiant flux such that a radiant fluence on the skin of a user of at least 1 j/cm2 is achieved by application of the treatment light pulse, wherein the light emission unit has at least two selectable active areas of first led dies, where the selectable active areas have different sizes, and at least three second led dies are mounted on the substrate at locations suitable for visibly indicating each of the selectable active areas.. .
Braun Gmbh

Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health

This invention provides pharmaceutical and cosmeceutical compositions, including anti-skin cancer compositions, n containing propolis and cyclodextrin, and compositions comprising one or more compounds present in propolis, including compositions comprising one or more compounds present as an inclusion complex with cyclodextrin. Methods of using such compounds and compositions, in particular in the treatment or prevention of skin cancers and skin disorders, and in enhancing skin health, are also provided..
Manuka Health New Zealand Limited

Nitric oxide topical application apparatus and methods

A topical application of nitric oxide may be provided by two separate containers, each containing an active component media to produce nitric oxide when combined. For example, a nitrite component media may be contained in one dispenser and an acidified component media may be contained in another dispenser.
Syk Technologies, Llc

Silicone-based biophotonic compositions and uses thereof

The present disclosure provides silicone-based biophotonic compositions and methods useful in phototherapy. In particular, the silicone-based biophotonic compositions of the present disclosure include a silicone phase and a surfactant phase, wherein the surfactant phase comprises at least one chromophore solubilized in a surfactant.
Klox Technologies Inc.

Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)

This disclosure pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7 diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiaziniumcompounds”) including methythioninium chloride (mtc) (also known as methylene blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (nos); nitrosyl reduction (nr); thiosulfonic acid formation (tsaf); oxidative coupling (oc); cr(vi) reduction (cr); isolation and purification of zwitterionic intermediate (iapozi); ring closure (rc); chloride salt-formation (csf); one of: sulphide treatment (st); dimethyldithiocarbamate treatment (dt); carbonate treatment (ct); ethylenediaminetetraacetic acid treatment (edtat); organic extraction (oe); and recrystallisation (rx).
Wista Laboratories Ltd.

Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases

Behavioral pharmacological data with the compound of formula (i), a novel and selective 5ht2a/2c receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing mk-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an mptp primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent.
Acadia Pharmaceuticals Inc.

Biophotonic compositions comprising halogen and uses thereof

The present disclosure provides biophotonic compositions containing halogen ions and/or halogen salts and methods useful in phototherapy. In particular, the biophotonic compositions comprising halogen of the present disclosure include at least one chromophore; and halogens and/or halogen salts such ki, or kcl, or kbr, or csbr, or mgbr2, or znbr2, or naf, or nacl, or nabr, or i2, or i3−, or br2, or cl2.
Klox Technologies Inc.

Abrasive skin treatment device

An abrasive skin treatment device including a handle portion, a head portion including an exfoliating element, and a unitary pivoting mechanism providing relative movement between the handle portion and the head portion along at least two planes.. .
Telebrands Corp.

Abrasive skin treatment device

An abrasive skin treatment device including a handle portion, a head portion including an exfoliating element, and a unitary pivoting mechanism providing relative movement between the handle portion and the head portion along at least two planes.. .
Telebrands Corp.

Method and an providing a multitasking view

According to an aspect, there is provided a method and an apparatus for providing a multitasking view. Task information of a task executed on a first device and a preview image of the executed task is received.
Microsoft Technology Licensing, Llc

Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity

The γc-family cytokines, interleukin-2 (il-2), interleukin-4 (il-4), interleukin-7 (il-7), interleukin-9 (il-9), interleukin-15 (il-15), and interleukin-21 (il-21), are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools.
Bioniz, Llc

Pharmaceutical composition for preventing or treating skin rash

Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event..
Dong-a University Research Foundation For Industry-academy Cooperation

Method for producing mycosporine-like amino acid using microbes

Provided are: a method for producing a mycrosporine-like amino acid (maa) that includes a step in which microbes are cultivated that produce maa on the outside of bacterial cells, a step in which the bacterial cells and extracellular culture fluid are separated, and a step in which the maa is recovered from the extracellular culture fluid; an maa indicated by formula (1), an maa produced using this method, or an ultraviolet-absorbing composition including the maa indicated by formula (1); and a composition including the maa produced using this method or the maa indicated by formula (1), for preventing at least one symptom or disease selected from a group comprising acute skin reactions, aging of the skin, and skin cancer.. .
Nagase & Co., Ltd.

Sensor inserter having introducer

Methods, device and system for providing a sensor insertion assembly including an inserter housing, an introducer including a body portion having a proximal end and a distal end and a shaft portion comprising a channel and a distal end, the shaft portion extending downwardly from an edge of the body portion, the shaft portion including a holding member disposed along a length of the channel, the holding member configured to substantially releasably retain a sensor, an on-body electronics unit, wherein the introducer is configured for insertion of the sensor through an aperture in the on-body electronics unit prior to insertion through skin and a drive mechanism included in the inserter housing and operatively coupled to the introducer, wherein the drive mechanism drives the introducer and retained sensor through the skin are provided.. .
Abbott Diabetes Care Inc.

Device, system, method and kit for preparing skin

A skin treatment device having a substrate having a first surface and a second surface, and an adhesive layer covering at least a portion of the first surface of the substrate. When the adhesive layer is applied to the skin surface of a mammal and removed, hair is removed at the follicle.
Full Power Aed, Llc

Nurr1 as a genetic target for treating levodopa-induced dyskinesias in parkinson's disease

Methods of treating movement disorders by reducing the activity of nurr1 are disclosed. These methods are particularly applicable to subjects suffering from parkinson's disease who have either developed levodopa-induced dyskinesia (lid) or are at risk of developing lid.
Board Of Trustees Of Michigan State University

Enantiomers of 8-hydroxyquinoline derivatives and the synthesis thereof

The subject matter of the invention furthermore relates to a novel, stereoselective synthesis for the preparation of the novel enantiomer derivatives according to the invention. The novel medicinal and/or pharmaceutical compositions comprising these enantiomers are suitable for the treatment of the named diseases, and the enanatiomers are used for manufacture of these compositions.

Skin lightening compounds

The present invention provides a compound of formula i, ii or iii or a salt or prodrug derivative thereof that is a skin-lightening agent useful for the inhibition of melanin synthesis and/or the removal of existing melanin to function as a skin-lightening agent.. .
Wisys Technology Foundation Inc.

Composition comprising gpcr19 agonist as an active ingredient for preventing or treating allergic dermatitis

The present invention is about a pharmaceutical composition, an oral preparation, and an injection preparation containing a g protein-coupled receptor19 (gpcr19) agonist, specifically sodium taurodeoxycholate(hy2191) and its derivative, as an active ingredient for preventing or treating allergic skin diseases. The present invention is also about an external preparation and a cosmetic composition containing said pharmaceutical composition for preventing and improving allergic skin diseases.
Shaperon Inc.

Method for evaluating condition of skin dryness

To provide a method for quickly and accurately evaluating a condition of skin dryness and a method for efficiently searching a substance to improve dry skin. A method for evaluating a condition of skin dryness, the method comprising measuring the expression levels of agr2 and/or agr3 in skin cells collected from subjects..
Kao Corporation

Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria

This disclosure provides, inter alia, systems and methods for testing products for ammonia oxidizing bacteria, quality control, and providing products with ammonia oxidizing bacteria. The systems and methods herein may be used, inter alia, to treat diseases associated with low nitrite levels, skin diseases, and diseases caused by pathogenic bacteria..
Aobiome Llc

Urea and amide derivatives of aminoalkylpiperazines and use thereof

The compounds can be used for treating a patient suffering from a condition that is capable of treatment with a partial agonist or antagonist of the dopamine d2/d3 receptors. The compounds are especially useful for patients suffering from schizophrenia, depressions, neurodegenerative diseases such as parkinson's, dyskinesias, substance abuse and relapse to substance abuse and addiction to substances such as cocaine, methamphetamine, nicotine and alcohol, glaucoma, cognitive disorders, restless leg syndrome, attention deficit hyperactivity disorders, hyperprolactinemia, autism, motor disturbances such as akathisia, rigor, dystonias as well as various disorders of the urinary tract and other neurologic disorders.

Radio frequency skin treatment device

The invention relates to a device (1) for skin treatment comprising a non-circular symmetrical outer electrode and at least two inner electrodes (20; 22) surrounded by the outer electrodes. An rf generator (16) is arranged to supply an rf voltage between the inner electrodes and the outer electrode.
Koninklijke Philips N.v

Centrosymmetric radio frequency electrode configuration for skin treatment

The invention relates to a device (100) for rf skin treatment comprising an outer electrode (2) arranged on an operational side (15) of the device. The outer electrode has an annular or equilateral polygonal shape.
Koninklijke Philips N.v.

Hatching fluid enzymes and uses thereof

The present invention relates to various polypeptides from fish hatching fluid, their encoding nucleic acid sequences, pharmaceutical compositions comprising said polypeptides and nucleic acid molecules and their use in various medical and cosmetic applications to the skin, particularly for moisturizing skin and/or for exfoliation of the horny layer of the skin for treating or preventing skin disorders or conditions in an animal.. .
Aqua Bio Technology Asa

Systems and methods for storage and delivery of ammonia oxidizing bacteria

This disclosure provides, inter alia, systems and methods for storage and delivery of ammonia oxidizing bacteria, and preparations comprising ammonia oxidizing bacteria. The ammonia oxidizing bacteria may be provided in a container or a kit, with one or more other components that may enhance delivery.
Aobiome Llc

Methods and compositions for sleep disorders and other disorders

Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving the 5-ht2a, sert and/or dopamine d2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or parkinson's disease or any combinations..
Intra-cellular Therapies, Inc.

Skin treatment devices with locking mechanisms

Devices, kits and methods described herein may be for wound healing, including the treatment, amelioration, or prevention of scars and/or keloids by applying and/or maintaining a pre-determined strain in an elastic skin treatment device that is then affixed to the skin surface using skin adhesives to transfer a generally planar force from the bandage to the skin surface. Applicators are used to apply and/or maintain the strains, and some of the applicators are further configured to provide at least some mechanical advantage to the user when exerting loads onto the skin treatment device..
Neodyne Biosciences, Inc.

Novel preparing ph dependent ultra small polymeric nanoparticles for topical and/or transdermal delivery

The invention provides a new method for preparing ultra-small polymeric-lipidic delivery nanoparticles (usdns) that were synthesized by a nanoprecipitation method followed by a layer-by-layer nanodeposition. The usdns particle size can be controlled between 5-25 mn and provides loading capacities of 22.12% to 72.08%.
Indagomed. Llc

Breathing assistance apparatus

A mask with cushion that has an outer film is disclosed. The film may be self-skinning or a film formed about or glued to the cushion body.
Fisher & Paykel Healthcare Limited

Portable medical treatment system and use

A medical treatment system including a treatment chamber, a source of an aqueous mist containing a medication, a source of an oxygen-enriched gas, and a control system adapted to alternately surround a human body part with a mist containing a medication and the oxygen enriched gas, which can be used to treat various skin disorders including infected lesions, bacterial infections such as acne (i.e. Propionibacterium acnes), fungal infections such as athlete's foot (i.e.
Wound Care, Inc.

Silicone-based composition for skin treatment

The present embodiments may relate to topically delivered compounded medications for the treatment of scar tissue, skin disorders, and/or other ailments. In one aspect, a transdermal cream or gel may provide for the effective administration of multiple medications simultaneously.
Cmpd Licensing, Llc

Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.. .
Allergan, Inc.

System for continuous monitoring of body sounds

A wearable monitoring system includes a microelectromechanical (mems) microphone to receive acoustic signal data through skin of a user. An integrated circuit chip is bonded to and electrically connected to the mems microphone.
International Business Machines Corporation

Method for selecting and controlling second work process during first work process in multitasking mobile terminal

Provided is a method for controlling a plurality of work processes in a multitasking mobile terminal, and more particularly, a method for selecting a second work process during a first work process and controlling a predetermined function of the selected second work process. In the controlling method, icons corresponding to the respective work processes are displayed in response to a user command, and a desired work process is selected through the displayed icons.
Pantech Inc.

Mir-21-3p inhibitors in skin disorders

The present invention is related to mir-21-3p inhibitors, which are particularly useful in the prevention and/or treatment of skin disorders.. .
Universite De Lausanne

Compositions and methods for treating bone, joints and cartilage

Briefly stated, the present invention provides compositions and methods for treating or preventing joint injuries utilizing hair follicle derived non-bulbar dermal sheath (“ndbs”) cells. Within one aspect of the invention methods are provided for isolating nbds cells, comprising the steps of: (a) preparing vital hair; (b) cleaving the hair prepared in step (a) to remove the hair follicle bulb; (c) isolating non-bulbar dermal sheath tissue; and (d) cultivating the isolated non-bulbar dermal sheath tissue to produce nbds cells.
Replicel Life Sciences Inc.

Microblister skin grafting

The present invention generally relates to devices for harvesting a skin graft(s). The present invention provides a blister raising device integrated with a member for cutting the blister..
Kci Licensing, Inc.

Imaging skin cancer detection device

The diagnostic methods of the invention are based on external imaging of lesions combined with an image taken with sub skin illumination revealing under the skin structures. A combination of the two images increases the available data, offering a better diagnostic tool..

Skin treatment apparatus

A skin treatment apparatus, preferably an epilator, comprising at least one detector for detecting approximation and/or contact with the skin and a control unit to actuate the device depending on the signal received from the detector. The control unit has at least one regulator which increases the speed of the drive unit upon detection of an increased resistance and/or current consumption by a sensor and/or decreases the speed of the drive unit upon detection of an decreased resistance and/or current consumption by a sensor..
Braun Gmbh

Skinning knife with removable blade

A skinning knife includes a handle and a blade carrier coupled to the handle, the blade carrier including a mount having a mounting surface, a boss extending outward from the mounting surface, and a spring including a front portion, a middle portion, and a rear portion. The skinning knife also includes a blade including a sharpened edge, a body, and a slot formed through the body, where the slot extends in a longitudinal direction from a front end to a rear end and includes a narrow portion of a first width and a wide portion of a second width greater than the first width.
Fiskars Brands, Inc.

Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide

An anti-microbial preservative for use in ophthalmic and dermatologic products. The preservative includes from about 0.005 wt.
S.k. Pharmaceuticals, Inc.

Hand recognizing method, system, and storage medium

Disclosure is a hand recognizing method including: acquiring a binary image into which an image is segmented based upon the skin color of a human body; extracting a connectivity domain in the binary image as a connectivity domain to be recognized; calculating a feature vector of a corresponding sample of the connectivity domain to be recognized; calculating the distances between the feature vector of the connectivity domain to be recognized, and feature vectors of hand sample connectivity domain, and the distances between the feature vector of the connectivity domain to be recognized, and feature vectors of non-hand sample connectivity domains; obtaining k samples with the shortest distances, determining whether the number of hand samples among the k samples is more than the number of non-hand samples, and if so, then determining that the connectivity domain to be recognized is a hand feature, wherein k represents a positive odd number.. .
Le Shi Zhi Xin Electronic Technology (tian Jin) Limited

Systems and methods for distinguishing facial features for cosmetic application

A media editing device obtains a digital image, and a facial region of an individual in the digital image is identified by a facial region analyzer. A plurality of facial features of the facial region is identified by a facial feature identifier.
Perfect Corp.

Dynamic data masking of post-output database data

Dynamic data masking by intercepting data derived from a database, creating a tabular representation of the data, and masking any of the data in accordance with a masking policy that specifies which of the data are to be masked if a masking condition is met, where the masking condition references the tabular representation of the data using a tabular positional reference.. .
International Business Machines Corporation

Method and composition for treating cancer or skin lesion using a vaccine

A method for treating or reducing the incidence of recurrence of cancer, benign tumors or hpv-associated lesions, including skin cancer, and particularly squamous cell carcinoma (scc and basal-cell carcinoma, by administering one or more doses of hpv recombinant vaccine to a patient.. .
Hpvvax, Llc

Topical formulation for skin care

Disclosed herein is a method of preparing a subject's cells for topical treatment of a subject in need. Also provided is a topical formulation and methods of treating a subject suffering a skin disorder and pain using the topical formulation.
Aesthetics Biomedical, Inc.

Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof

Pharmaceutical compositions for treating, mitigating or preventing inflammatory skin diseases, disorders and/or pathologies are described, the compositions comprising a tetracycline-class antibiotic(s), omega fatty acid(s), and/or nicotinic acid or derivatives thereof. Methods for fabricating the compositions and using them are also described..
Imprimis Pharmaceuticals, Inc.

Corticosteriod containing foam compositions and manufacture thereof

The present invention provides a method of manufacturing foamable, corticosteroid containing compositions as well as methods for treating various skin diseases.. .
Therapeutics Inc.

Halobetasol foam composition and use thereof

The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol..
Therapeutics Inc.

Heteroaromatic compounds and their use as dopamine d1 ligands

And pharmaceutically acceptable salts thereof and n-oxides thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds (n-oxides thereof or or pharmaceutically acceptable salts of the compound or the n-oxides) and the uses of such compounds (n-oxides thereof or or pharmaceutically acceptable salts of the compound or the n-oxides) for the treatment of d1-mediated (or d1-associated) disorders including cognitive and motivational impairments and negative symptoms associated with illnesses such as schizophrenia, depression, bipolar disorder, parkinson's disease, mild cognitive impairment (mci), alzheimer's disease, lupus, huntington's disease, parkinson's, dyskinesia, adhd, post-traumatic stress disorder, autism spectrum disorder, treatment-resistant depression, major depressive disorder (mdd), drug dependence, tourette's syndrome, tardive dyskinesias as well as impairments associated with age, chronic stress, sleep deprivation, combat, chronic fatigue; endocrine or metabolic diseases such as hyperglycemia, dislipidemia, diabetes, obesity, and sepsis; and cardiovascular disorder such as hypertension. The present invention further provides a d1 agonist with reduced d1r desensitization, a d1 agonist with a reduced β-arrestin recruitment activity relative to dopamine, a d1 agonist interacting significantly with the ser188 but not significantly with the ser202 of a d1r when binding to the d1r, a d1 agonist interacting less strongly the asp103 and interacting less strongly with the ser198 of a d1r when binding to the d1r, and their uses..

Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them

The invention is directed to a stable complex with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound sirolimus or derivatives thereof, which is useful in the prophylaxis of organ rejection in patients receiving renal transplants, in the treatment of psoriasis, facial angiofibromas associated with tuberous sclerosis, fibrofolliculomas found in birt-hogg-dubé syndrome, chronic erosive oral lichen planus, early stage cutaneous t-cell lymphoma, treatment of autoimmune active anterior uveitis, dry eye syndrome, age-related macular degeneration, diabetic macular edema, noninfectious uveitis, telangiectasia, inflammatory skin diseases (dermatitis, including psoriasis and lichen ruber planus), pachyonychia congenita and in the suppression of angiogenesis pathways. More specifically, the complex of the present invention possesses increased apparent solubility, permeability and enhanced biological performance including significantly improved exposure, earlier tmax, higher cmax and higher trough concentrations at 24 hours which will allow the reduction of the dose..
Druggability Technologies Ip Holdco Limited

Topical skin care formulations comprising plant extracts

Disclosed are methods of treating skin with topical skin compositions comprising at least one plant extract.. .
Mary Kay Inc.

Topical skin care formulations comprising plant extracts

Disclosed are methods of treating skin with topical skin compositions comprising at least one plant extract.. .
Mary Kay Inc.

Mass spectrometry imaging of benign melanocytic nevi and malignant melanomas

A method of differentiating benign melanocytic nevi from malignant melanomas is disclosed. The method generally includes subjecting a skin lesion sample from a patient to mass spectrometry to obtain a mass spectrometry protein profile.
Yale University

Information processing apparatus, information processing system, information processing method, and recording medium

There is provided at least one information processing apparatus capable of easily generating a skin color model in which peripheral darkening is considered that is possibly occurring due to an imaging apparatus. At least one embodiment of the information processing apparatus includes an acquisition unit configured to acquire a first image in which a predetermined object is captured with a predetermined exposure condition, and at least one second image in which the predetermined object is captured with an exposure condition or a plurality of exposure conditions different from the predetermined exposure condition; an extraction unit configured to extract color information relating to the predetermined object based on the first image and the at least one second image; and a generation unit configured to generate a color table based on the extracted color information..
Canon Kabushiki Kaisha

System for determining, dispensing, and mixing blended composition for skin treatment

A system and method is provided for providing a cosmetic composition to a user. The system includes an apparatus configured to dispense at least one cosmetic composition into a output container; a user interface configured to receive information about the user; and circuitry configured to receive the information about the user and determine one or more cosmetic compositions to be dispensed into the output container based on the information about the user received at the user interface..
L'oreal

Method and electronic device for skin color detection

The present disclosure discloses a method and a device for skin color detection. The method includes: reading an rgb image, and converting the rgb image from an rgb color space to an r-g color space, and obtaining an image to be detected; traversing and reading each pixel in the image to be detected, and calculating a first probability density of the pixel under a skin gaussian mixture model and a second probability density of the pixel under a non-skin gaussian mixture model according to a pre-established gaussian mixture model; calculating the posteriori probability of the pixel belonging to a skin region according to the first probability density and the second probability density of the pixel; and attributing the pixel to the skin region when determining that the posteriori probability is greater than a preset posteriori probability threshold.
Le Shi Zhi Xin Electronic Technology (tian Jin) Limited

Apparatus for dispensing and mixing blended composition for skin treatment

An apparatus is provided for dispensing a cosmetic composition, including: a cartridge holder configured to hold at least one cartridge that stores a cosmetic composition, the cartridge holder being configured to move the cartridge to a predetermined location; a container receiving area configured to hold a output container beneath the predetermined location; circuitry configured to determine the cosmetic composition in the cartridge holder, control the cartridge holder to move the cartridge holder to the predetermined location based on the determination, and control the cartridge to dispense the cosmetic composition into the output container; and a mixer configured to hold the output container and subject the output container to a predetermined movement to cause contents of the output container to mix together.. .
L'oreal

Biophotonic materials and uses thereof

The present disclosure provides biophotonic materials and methods useful in phototherapy. In particular, the biophotonic materials of the present disclosure include a cohesive matrix, and at least one chromophore, wherein the at least one chromophore can absorb and emit light from within the biophotonic material.
Klox Technologies Inc.

Combination of n-acetyl glucosamine with abscisic acid and uses thereof

Compositions comprising n-acetyl glucosamine and abscisic acid, a pharmaceutically acceptable salt, ester, or isomer thereof, are disclosed. The present invention also relates to the use of such a composition for skin modulation, immune modulation, and tissue growth, such as anti-aging, wound healing, skin graft healing, and stem cell maturation and signaling..

Topical skin compositions having proteins and methods of use

There is provided a topical skin composition directed to one or more desired benefits. The composition includes one or more proteins selected based on the desired skin benefit to be derived by application of the topical skin composition.
Dermaforce Holdings, Llc

Client-server system and terminal

A client-server system includes a server, at least one of a first client and a second client, and server-side computer resources which are attributed to the at least one of a first client and a second client so as to implement a server-side multitasking. The at least one of a first client and a second client distribute the server-side computer resources input-dependently so as to implement a client-side and input-dependent multitasking..

Bioluminescence tomography reconstruction based on multitasking bayesian compressed sensing

Implementations of the present disclosure relate to methods for reconstruction for bioluminescence tomography based on a method of multitask bayesian compressed sensing in the field of medical image processing. The method includes the following operations.

Medical skin examination device

A medical skin examination device configured to diagnose a skin lesion includes: a first storage unit configured to store an original first skin image related to a dermoscopy structure imaged via a dermoscope; an image conversion unit configured to apply high dynamic range (hdr) conversion processing to the first skin image and obtain a second skin image in which the dermoscopy structure is made clear and salient; a second storage unit configured to store the second skin image; and a display control unit configured execute control so as to display at least one of the first skin image and the second skin image.. .

Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response

The invention provides novel immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit or suppress tlr-mediated signaling in response to a tlr ligand or tlr agonist.

Cosmetic skin rejuvination

A device for cosmetic treatment of human skin, including: a needle for inserting into the skin; a dc power source electrically connected to the needle for providing negative current to the needle; an anode that is electrically connected to the dc power source to receive positive current, and that is adapted to be placed in contact with the skin of the person into which the needle is inserted to form a closed electrical circuit; at least one rf transmitter coupled to the needle for radiating the area around where the needle is inserted to provide heat while the needle is deployed.. .

Treatment of a skin lesion

The invention provides a spray applicator (1) for topical treatment, the spray applicator (1) comprising a container (2) comprising a treatment liquid (52) under pressure and a propellant (51), wherein the container (2) is in fluid connection with a spray valve system (4) for application of at least part of the treatment liquid (52) on a topical area, wherein the treatment liquid (52) comprises an acid, wherein the container (2) comprises a container wall (20) having a top layer (22) and a top layer coating (21) on said top layer (22), wherein the top layer (22) optionally comprises a metal and wherein the top layer coating (21) comprises a polymer and/or a resin.. .

Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems

The present invention teaches compositions, methods and kits for treating skin conditions, including dandruff. In various embodiments, the compositions include an effective amount of one or more probiotic microorganism of vaginal origin and/or a fraction thereof and/or a component of the metabolome for preventing and/or treating skin disorders of the scalp..

Skin color-improving agent and composition for improving skin color

A tocopherol phosphoric acid ester represented by a following formula (1) (in the formula, r1, r2, and r3 each independently represents a hydrogen atom or a methyl group,), a pharmacologically-acceptable salt thereof, or a solvate thereof for use in the improvement of skin color.. .

Chart for evaluating skin color and its application to efficacy evaluation of anti-aging and skin lightening products

The present invention relates to charts, stacks and methods for evaluating skin color of a mammalian subject. The chart may include a substrate and an indicia visible from a first side of the substrate that includes a plurality of images of mammalian skin tones having varying degrees of yellowness, wherein each indicia is correlated with an index value.
Access Business Group International Llc

Methods of treating skin disorders using an anti-il-31ra antibody

The present invention relates to methods of treating patients suffering from contact dermatitis, drug induced delayed type cutaneous allergic reactions, toxic epidermal necrolysis, cutaneous t cell lymphoma, bullous pemphigoid, alopecia aereata, vitiligo, acne rosacea, prurigo nodularis, scleroderma, herpes simplex virus, or combination by administering an il-31ra antagonist.. .
Zymogenetics, Inc.

A skin treatment device for locally treating skin

A skin treatment device (100) for locally treating skin with light is provided that comprises a tip (128), a light emission element (106, 108), a safety mechanism comprising an optical element (124) and an optical element positioning structure (122). The optical element receives a converging light beam from the light emission element.
Koninklijke Philips N.v.

Electromagnetic energy applicator for personal aesthetic skin treatment

An apparatus for safe personal aesthetic skin treatment including a carrier with a plurality of voltage applying electrodes arranged so that at least one electrode operative to contact the skin at any one time, an electrode-to-skin contact detecting mechanism, and a controller communicating with and operative to receive information from the mechanism regarding the status of the electrode-to-skin contact and limit the number of simultaneously activated electrodes such as to enable safe skin treatment and avoid skin ablation.. .
Syneron Medical Ltd

Skin graft product

An apparatus and method for the production of substitute skin that advantageously reduces the amount of donor dermal cells needed from non-wound areas of a patient having a wound to be auto-grafted is reduced by using all of the harvested skin cells. A 3d printer is used to construct a wound graft product from the harvested skin cells without wasting any of the harvested skin cells.
Dermagenesis Llc

Botanical formulations

Disclosed is a topical skin composition, and methods for its use, that includes arctium lappa root extract, epilobium angustifolium extract, and cystoseira amentacea/caespitosa brachycarpa extract.. .
Mary Kay Inc.

Method of treating pre-cancerous lesions with glyphosate, and compositions thereof

A method for treating a pre-cancerous skin lesion on a human subject with glyphosate is described, along with compositions for said treatment.. .

Topical compositions and methods for skin lightening

Embodiments of the invention are generally directed to compositions useful for reducing pigmentation in the skin. The composition may further include other depigmenting agents such as nicotinamide and its melanasome transfer-inhibiting derivatives, 3,3′-thiodipropanoic acid and its tyrosinase-inhibiting derivatives, or resorcinol and its tyrosinase-inhibiting derivatives, in a topically acceptable vehicle..
Avon Products, Inc.

Light-based measurement system and a collagen denaturation measurement and a skin treatment system

The measurement system 110 comprises a light source 120 configured and arranged for emitting a light beam via a polarization modulator 130 to a target position inside the skin 160, wherein the polarization modulator 130 is configured and arranged to simultaneously provide, in use, a first and a second region in a cross-section of the light beam in the target position, the first and the second region being distinct and having a corresponding first and second direction of polarization, the first and the second polarization direction being different from each other, and the measurement system also comprises a detection unit 150 to simultaneously detect a first and a second intensity of reflected light 145, the first intensity corresponding to light reflected from the first region of the light beam in the target position 160, and the second intensity corresponding to light reflected from the second region of the light beam in the target position 160, and the measurement system further comprises a processor being coupled to the detection unit 150 for determining a difference between the first and the second intensity.. .
Koninklijke Philips N.v.

Mobile terminal and controlling method thereof

A mobile terminal and controlling method thereof are disclosed, by which a selection and/or execution of an application can be designated using a list of applications currently executed in a multitasking environment. The present invention includes a display unit, a user input unit configured to receive an input of a command from a user, and a controller, when a plurality of applications are being executed, if there is a first input via the user input unit, controlling a list of a plurality of the currently executed applications to be displayed on a first region, the controller, if one of at least one or more applications running in the background in the list is selected by a second input via the user input unit, controlling the selected application to be displayed on a second region of the display unit by having a prescribed visual effect applied thereto..
Lg Electronics Inc.

Antibodies against human sodium channel nav1.9 and uses thereof for the diagnosis of inflammatory skin diseases

Antibodies against the human sodium channel nav 1.9 are described. Also described, is the use of such antibodies in the diagnosis of inflammatory skin diseases.
Universite D'aix-marseille

Compounds comprising 1,1a,2,5a-tetrahydrospiro[indole-3,2a-pyrrole]-2,5a-dione system as inhibitors p53-mdm2 protein-protein interaction

A spirooxoindole compound represented by the formula selected from the group consisting of formula (ia) and (ib), wherein all symbols are as defined in the description. The compound can find use in a method of prevention and/or treatment of diseases selected from the group consisting of cancer, immune diseases, inflammatory conditions, allergic skin diseases associated with excessive proliferation, and viral infections..
Adamed Sp. Z O.o.

Skin treatment lotion

A system and method for a skin treatment lotion. The lotion has a protecting agent, a moisture absorber, a binding agent, water, and an antibiotic agent or hydrocortisone.

Topical composition for skin treatment to reduce lines and wrinkles of the face and body using a dual dna repair mechanism to address damage caused by aging and ultra-voilet induced damage to the skin with combination of skin turgor enhancement compounds

A topical composition for anti-aging and anti-uv damage treatment of the skin includes water soluble extract of uncaria species, arabidopsis thaliana extract, alpha lipoic acid, dimethylethanolamine, tetrahexyldecyl ascorbate, dimethyl sulfoxide, glycyrrhiza glabra (licorice) root extract, methylsulfonylmethane, phytosterols, d-ribose, tocotrienol, tocopherol, glucosamine hydrochloride, pisum sativum extract; silicates of sodium, magnesium and aluminum, and a dermatologically acceptable liposomal delivery medium. The composition is useful in a method using it for anti-aging skin treatment effecting dna repair in both the nucleus and the mitochondria.

Systems and methods for medical image segmentation and analysis

The present disclosure includes systems, methods, and computer-readable medium for monitoring and analyzing skin lesions. A sequence of images are be received, and color correction, contour detection, and feature detection are performed on the images.
Massachusetts Institute Of Technology

Gesture based human machine interface using marker

The present disclosure relates to system and method for gesture recognition for emulating a mouse for human machine interface wherein displacements, direction of displacements of cursor as also double click actions of mouse can be emulated by instinctive hand gestures. The method uses a marker as gesture interface and therefore does not depend on hand segmentation techniques, which suffer from deficiencies related to lighting conditions, variation of skin color from person to person and complexities of background..
Centre For Development Of Telematics

Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages

The invention is an increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of skin and skin appendages. The allylamine active ingredient is prepared in an acidic environment; the acidic environment altering the physiochemical properties of the active ingredient resulting in the active ingredient having a positive charge.
Biophile Corporation, Ltd.

Skin cancer treatment

For use in the treatment of skin cancer such as basal cell carcinoma.. .

Lower eyelid treatment

The invention relates to a lower eyelid treatment device (1), which comprises a skin treatment structure (3) having a protruding shape which is able to perform a periodical first movement through a stationary reference point (p) in a skin treatment zone (8) of the device. Said periodical first movement occurs in the reference point (p) at a frequency within a frequency range between 0.5 hz and 3.0 hz.
Koninklijke Philips N.v

Devices and methods for protecting the eye from adjacent skin treatments

A skin care apparatus suitable for use in proximity to a subject's eyes. The apparatus includes a treatment device and a stimulus device.
L'oreal

Ultrasonic scalpel

An ultrasound scalpel that may be used for surgical operations is disclosed in this invention. The ultrasound scalpel comprises an ultrasound generator, housing, transducer horn, retaining member and scalpel blade.

Method and system for implementing generation locks

A system and method for implementing a generation lock for protecting a data structure is provide. The systems and methods synchronizes read and write transactions for a protected data structure in a multitasking environment and provides low latency and improved scalability.
Wind River Systems, Inc.

Topical skin care formulations comprising plant extracts

Disclosed are topical skin compositions and corresponding methods for their use that include plant extracts. One such composition can include a tnf-α inhibitor, wherein said inhibitor is an aqueous extract from the whole plant of polygonum multiflorum, an antioxidant and a tyrosinase inhibitor, wherein said antioxidant and tyrosinase inhibitor is an aqueous extract from the whole plant of lonicera japonica, and a dermatologically acceptable carrier, wherein the composition can include at least 50% by weight of water..
Mary Kay Inc.

Thermosetting biophotonic compositions and uses thereof

The present disclosure provides thermosetting biophotonic compositions and methods useful in phototherapy. In particular, the thermosetting biophotonic compositions of the present disclosure include block copolymer and at least one chromophore solubilized in the block copolymer.
Klox Technologies Inc.

Controlled strain skin treatment devices and methods

Devices, kits and methods described herein may be for wound healing, including but not limited to the treatment, amelioration, or prevention of scars and/or keloids. The packaging, manipulation elements, applicator and/or tensioning device maybe used to apply and/or maintain a strain in an elastic dressing..
Neodyne Biosciences, Inc.

Hand suspension fixture

Described is a hand suspension fixture for recovering from skin grafts on human hands. The hand suspension fixture generally comprises five retention fixtures each adapted to connect to one of five flexible members at a first end.

Managing thread execution in a multitasking computing environment

A thread in a computing system is processed for execution of instructions to perform an action. The action is one of the following: accessing a shared resource or executing a critical section of code.
International Business Machines Corporation

Managing thread execution in a multitasking computing environment

A thread in a computing system is processed for execution of instructions to perform an action. The action is one of the following: accessing a shared resource or executing a critical section of code.
International Business Machines Corporation

Phenyl-substituted nicotinic ligands, and methods of use thereof

Disclosed are compounds and methods of using them to treat a disorder selected from the group consisting of addiction, pain, obesity, schizophrenia, epilepsy, mania and manic depression, anxiety, alzheimer's disease, learning deficit, cognition deficit, attention deficit, memory loss, lewy body dementia, attention deficit hyperactivity disorder (adhd), parkinson's disease, huntington's disease, tourette's syndrome, amyotrophic lateral sclerosis, inflammation, stroke, spinal cord injury, dyskinesias, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, ganser's syndrome, migraine pain, bulimia, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, autism, mutism, trichotillomania, hypothermia, and disorders of sleep.. .
Duke University

Cancer treatments

This document provides methods and materials related to treating cancer (e.g., skin cancer). For example, methods and materials relating to the use of a composition containing albumin-containing nanoparticle/antibody complexes (e.g., abraxane®/anti-vegf polypeptide antibody complexes) to treat cancer (e.g., skin cancer) are provided..
Mayo Foundation For Medical Education And Research

Biophotonic hydrogels

The present disclosure provides biophotonic hydrogels and methods useful in phototherapy. In particular, the biophotonic hydrogels of the present disclosure include n-hydroxyethyl acrylamide (heaa), and at least one chromophore, wherein the at least one chromophore is not fully photobleached after photopolymerization.
Klox Technologies Inc.

Compositions and methods for treatment of inflammatory skin conditions using allantoin

Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof.
Scioderm, Inc.

Compositions and methods of treatment of inflammatory skin conditions using allantoin

Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof.
Scioderm, Inc.

Topical skin care formulations comprising plant extracts

Disclosed is a topical skin composition and corresponding methods for its use that includes an extract from phaseolus vulgaris, citris sinensis, wedelia trilobata, burretiodendron hsienmu, bauhinia brachycarpa var. Cavaleriei, cystacanthus paniculatus, caesalpinia minax, pueraria wallichii, tetracentron sinense, bridelia insulana, hedyotis verticillata, syzygium fruticosum, cercidiphyllum japonicum, bauhinia glauca, rhododendron siderophyllum, cudrania pubescens, cajanus cajan, wendlandia uvariifolia, siegesbeckia glabrescens, azolla imbricate, juncus bufonius, poikilospermum suaveolens, clerodendrum trichotomum var.
Mary Kay Inc.

Modulating gamma-c-cytokine activity

Embodiments relate to peptide antagonists of γc-family cytokines, which is associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools.
Bioniz, Llc

Urea compounds and their use as enzyme inhibitors

Or a pharmaceutically acceptable salt or derivative thereof. The compound may be used in the treatment or prevention of a disorder selected from appetite regulation, obesity, metabolic disorders, cachexia, anorexia, pain, inflammation, neurotoxicity, neurotrauma, stroke, multiple sclerosis, spinal cord injury, parkinson's disease, levodopa-induced dyskinesia, huntington's disease, gilles de la tourette's syndrome, tardive dyskinesia, dystonia, amyotrophic lateral sclerosis, alzheimer's disease, epilepsy, schizophrenia, anxiety, depression, insomnia, nausea, emesis, alcohol disorders, drug addictions such as opiates, nicotine, cocaine, alcohol and psychostimulants, hypertension, circulatory shock, myocardial reperfusion injury, atherosclerosis, asthma, glaucoma, retinopathy, cancer, inflammatory bowel disease, acute and chronic liver disease such as hepatitis and liver cirrhosis, arthritis and osteoporosis..

Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy

The invention also concerns a method for the protection or treatment of skin and hair damages of a mammal caused by chemotherapy. The invention further relates to a kit for the protection or treatment of hair damages caused by chemotherapeutic treatment consisting of a topical composition comprising microparticles together with free radical scavengers and a shampoo for an effective hair cleaning and supporting the hair treatment.

Composition for external use skin preparation, containing thioredoxin

Provided is a composition for an external use skin preparation, containing thioredoxin, and more specifically, to a composition which contains thioredoxin thereby providing an overall improvement in skin condition such as a remarkable improvement in skin moisturization, reduction in a transepidermal water loss, sebum control, pore contraction, an improvement in skin color through blood circulation improvement, and the like.. .
Amorepacific Corporation

Cosmetic skin-lightening composition

A method includes using such compositions.. .

Skin treatment composition

A composition for application to mammalian skin. The composition can include an emulsion comprising an oil phase.
3m Innovative Properties Company

Integrated tablet computer in hot and cold dispensing machine

Improvements a hot and cold dispensing machine is disclosed. The machine integrates a tablet computer with hot and cold dispensing machines, including coffee machines that transform the dispensing machine into a fully interactive machine that enables an unlimited number of features to be added as functionalities.

Novel tricyclic modulators of cannabinoid receptors

The compounds of the invention are modulators of cannabinoid receptors cb1 or cb2. The compounds can be used for the prevention or treatment of, e.g., pain, cancer, skin diseases, weight-associated disorders, chemical addictions, psychiatric disorders, neurodegenerative disorders, bone diseases, and inflammatory diseases.
The University Of Montana

Needle system

A needle system for penetrating to or passing thought an object or an organ comprising a semiconductor die, one or more needles, wherein the needles move relative to the die using one or more actuators. The actuators are controlled by a controller wherein the controller instruct the needle to penetrate into or to pass through and/or retract from the object or organ.

Integrated double cannula for ecmo

The present invention relates to an integrated double cannula for ecmo. The integrated double cannula is configured to be inserted into a blood vessel through skin for ecmo.
Samsung Life Public Welfare Foundation

Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.. .
Allergan,inc.

Polyvinylacetal resin for heat-developable photosensitive material and heat-developable photosensitive material

An object of the present invention is to provide: a polyvinyl acetal resin for a heat-developable photosensitive material capable of preventing skinning in the coating process of the photosensitive layer of the heat-developable photosensitive material, preventing deterioration of image characteristics and coloration of the coating solution, and suppressing the occurrence of odor at the time of producing the heat-developable photosensitive material and heat development. The present invention provides a polyvinyl acetal resin for a heat-developable photosensitive material used for a photosensitive layer of the heat-developable photosensitive material, which has a residual acetyl group content of 25 mol % or less, residual hydroxyl group content of 17-35 mol %, polymerization degree of 200 to 3,000, which is obtained by an acetalization of a polyvinyl alcohol mixture containing polyvinyl alcohol resins having different polymerization degrees, the content of the polyvinyl alcohol having a polymerization degree of 600 or less being 50 wt % or higher in the polyvinyl alcohol mixture..
Sekisui Chemical Co., Ltd.

Skinning of ceramic honeycomb bodies

An in situ inspection system and method to inspect a honeycomb body (122) skin in a skinning system. The inspection system includes a line illuminator (148) to generate a line illumination on the skin (136) perpendicular to an axial direction (112) of the honeycomb body travel, and a detector (152) to detect the line illumination scattered from the skin (136) and generate a signal based on the detected line illumination.
Corning Incorporated

Light-activated acne treatment

A skin treatment device uses blue-light therapy to treat acne or other skin conditions. The device includes a positioning mechanism that allows a user to position the device on a target treatment area.

Skin resurfacing device, controlling apparatus and controlling skin resurfacing device

The present invention provides a controlling apparatus for a skin resurfacing device performing a surgical procedure on a human skin with a surgical needle, including: a controller 20; a voltage regulator 50 configured to regulate a voltage supplied to the skin resurfacing device from a power supply 10 according to a control of the controller; and a starting switch 80 configured to turn on/off a supply of power between the voltage regulator and the skin resurfacing device, in which the controller controls the voltage regulator so as to output a preset jump start voltage to the skin resurfacing device every time the starting switch is turned on, if a jump start function that is a function of starting the skin resurfacing device is set by a starting voltage when an operating voltage of the skin resurfacing device is lower than the starting voltage of the skin resurfacing device at the time of the surgical procedure.. .

Composition, treating skin

A composition for wound healing and/or skin treatment comprises honey and a carbonate and/or bicarbonate salt. The salt is preferably capable of releasing co2.
Biomedical Concepts Llc

Treatment of inflammatory and infectious skin disorders

Disclosed herein is a composition comprising of resveratrol and/or derivatives thereof and/or functionally related compounds and benzoyl peroxide and/or derivatives thereof and/or functionally related compounds for the treatment of acne and other inflammatory or infectious skin disorders. Also disclosed are methods of treating acne and other inflammatory and infectious skin disorders using the compositions described herein..
The Regents Of The University Of California

Cosmetic compositions for bleaching the skin

The invention relates to a cosmetic composition for bleaching the skin, which includes a) at least one oily plant extract from the glycyrrhiza genus and b) at least one ascorbic acid ester. The invention further relates to the cosmetic, nontherapeutic use of the cosmetic composition according to the invention to treat excessive pigmentation, pigmentation disorders, age spots, and/or post-inflammatory hyperpigmentation of the skin, and to a method for producing a cosmetic skin-bleaching composition in the form of an o/w or a w/o emulsion, wherein an oily extract from licorice roots is dissolved in the water phase by the addition of an ascorbic acid ester..
Henkel Ag & Co. Kgaa

Dynamic data masking system and method

A system and method for providing dynamic data masking for databases through a data masking apparatus.. .
Hexatier Ltd

Novel compounds as diacylglycerol acyltransferase inhibitors

This invention relates to novel compounds which are inhibitors of acyl coenzyme a: diacylglycerol acyltransferase 1 (dgat-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to dgat-1 dysfunction or where modulation of dgat-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, genetic (type 1, type 5 hyperlipidemia) and acquired forms of hypertriglyceridemia or hyperlipoproteinemia-related disorders, caused by but not limited to lipodystrophy, hypothyroidism, medications (beta blockers, thiazides, estrogen, glucocorticoids, transplant) and other factors (pregnancy, alcohol intake), hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, cardiovascular outcomes, angina, excess hair growth (including syndromes associated with hirsutism), nephrotic syndrome, fibrosis such as myocardial, renal and liver fibrosis, hepatitis c virus infection and acne or other skin disorders.. .
Glaxosmithkline Llc

Treatment of inflammatory skin disorders

The invention relates to methods of using an effective amount of activated protein c (apc) to treat an individual for a skin disorder characterised by the presence of hyperproliferative keratinocytes.. .
Zz Biotech Llc

Method and system for assessing motion symptoms

A state of progression in an individual of a disease or treatment having motion symptoms is determined. A time series of accelerometer data is obtained from an accelerometer worn on an extremity of the person, over an extended period during everyday activities of the person.
Global Kinetics Corporation Pty Ltd

Electronic device using information on skin color type and control method thereof

An electronic device and method that detects an event related to the user's skin and performs a function corresponding to the event by using information on the skin color type of the user, and further provides a control method thereof. The occurrence of an event is detected that is related to at least a part of a user's body.
Samsung Electronics Co., Ltd.

Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors

The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of janus kinases and are useful in the treatment of diseases related to activity of janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.. .
Incyte Holdings Corporation

Treatment of hyperkinetic movement disorders

Methods for treating hyperkinetic diseases and disorders, such as tardive dyskinesia, are provided. In a certain embodiment, the potent vmat2 inhibitor (+)α-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol ((+)α-htbz) is used in the methods described herein for treating a subject in need thereof..
Neurocrine Biosciences, Inc.

Pyridine and pyrazine derivative for the treatment of cf

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type cftr to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (ibs, ibd, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed..
Novartis Ag

Matrix-metalloproteinase (mmp) inhibitory extract and methods of use thereof

A cosmetic skin care product comprising a therapeutically effective amount of a honey extract is described, the honey extract having a phenolic compound to saccharides ratio of at least 5 times greater than the raw honey from which the extract is derived and including a mixture of at least ethanol, water and one or more mmp inhibitory phenolic compounds.. .
Comvita Limited

N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use

The present invention relates generally to the field of pharmaceuticals and cosmetics. More specifically, the present invention pertains to certain n-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides of the following formula which are potent modulators (e.g., inhibitors) of an androgen receptor, and which are useful, for example, in therapy, for example, in the treatment of a dermatological disease or disorder; a disease or disorder of the sebaceous gland(s); acne; hyperseborrhoea; oily skin; seborrhoeic dermatitis; hyperpilosity or hirsutism; atopic dermatitis; or androgenic alopecia; especially acne.
Galderma Research & Development

Skin treatment device

A skin treatment device includes: a shell body; a pressing bar, formed with a first end mounted in the shell body and a second end protruded from one distal end of the shell body and formed with a squeezing part having a through hole; a bactericidal lamp, installed in the shell body and including a bactericidal light source capable of generating plural bactericidal light beams passing the through hole; and a cover member, disposed at one distal end of the shell body, served to cover the second end and including a light condensing lens disposed corresponding to the through hole and the bactericidal lamp. Accordingly, when the bacteria existed on the skin or in skin pores are exposed to the bactericidal light beams, the bacteria can be naturally deceased..
Kinpo Electronics, Inc.

Devices and methods for treating the skin

According to some embodiments, a skin treatment assembly comprises a handpiece comprising a distal end, the handpiece comprising a recess or cavity configured to receive a cartridge or other fluid container, a tip configured to be positioned along the distal end of the handpiece, the tip being configured to contact a skin surface of a subject during use, and at least one rollerball configured to extend to or near the tip, wherein the rollerball is configured to be in fluid communication with an interior of a cartridge or other fluid container secured to the handpiece, wherein the at least one rollerball is configured to contact the skin surface of the subject during use and to facilitate the delivery of fluids to said skin surface as the rollerball is moved relative to said skin surface.. .
Edge Systems Llc

Use of coumarin derivatives for the preparation of drugs for treating skin diseases

Wherein n equals 0 or 1, z represents o or s, r1 represents one group chosen among the group consisting of hydrogen, c1-c7 alkyl, substituted, or not, by a halogen, a hydroxyl or a —o—r12 group, wherein r12 is a c1-c7 alkyl, a group —ch2—o—co—r5 wherein r5 is chosen among a hydrogen atom and a c1-c7 alkyl, substituted or not by at least one halogen, a group —o—r13, wherein r13 is chosen among hydrogen and a c1-c7 alkyl, an amine or a —ch2-amine, r′1 represents a group chosen among hydrogen and —o—r14, wherein r14 is chosen among hydrogen and a c1-c7 alkyl, and r2 is chosen among the group consisting of a c1-c7 alkyl, a c3-c6 cycloalkyl, an aryl group, and an heteroaryl group for the treatment of pathologies involving excess activity of at least one member of the kallikrein family.. .

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (i) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, skin cancer.. .
Amderma Pharmaceuticals, Llc

Heteroaromatic compounds and their use as dopamine d1 ligands

And pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating d1-mediated (or d1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, ad, pd, or pharmacotherapy therapy), adhd, impulsivity, compulsive gambling, overeating, autism spectrum disorder, mcl, age-related cognitive decline, dementia, rls, parkinson's disease, huntington's chorea, anxiety, depression, mdd, trd, bipolar disorder, chronic apathy, anhedonia, chronic fatigue, post-traumatic stress disorder, seasonal affective disorder, social anxiety disorder, post-partum depression, serotonin syndrome, substance abuse and drug dependence, drug abuse relapse, tourette's syndrome, tardive dyskinesia, drowsiness, excessive daytime sleepiness, cachexia, inattention, sexual dysfunction, migraine, sle, hyperglycemia, atherosclerosis, dislipidemia, obesity, diabetes, sepsis, post-ischemic tubular necrosis, renal failure, hyponatremia, resistant edema, narcolepsy, hypertension, congestive heart failure, postoperative ocular hypotonia, sleep disorders, and pain.. .

Skin care system, device and method

The present invention relates to a skin care system (10), comprising: (i) a skin treatment device (12) for treating a skin of a user; (ii) a receiving unit (14) for receiving information on the skin of the user; and (iii) an evaluation unit (16) which is configured to evaluate the received information on the skin of the user and to determine based on said evaluation one or more personalized device settings for operating the skin treatment device (12). The skin treatment device (12) comprises a control unit (36) which is configured to operate the skin treatment device (12) upon initiation based on the determined one or more personalized device settings..
Koninklijke Philips N.v.

Fluid skin treatment systems and methods

The present invention relates to devices for dermatology and more particularly to fluid enhanced skin treatment system for skin rejuvenation that can optionally use an abrasive probe for removing epidermal layers while contemporaneously providing for the infusion of therapeutic fluids into the skin.. .

Use of a composition comprising arabic gum (ag) for improving gut impermeability

The use of a nutritional composition including arabic gum (ag) improves gut impermeability. The nutritional composition also improves conditions like abdominal pain, chronic or not, insomnia, bloating, flatulence, shortness of breath, gluten intolerance, malnutrition, muscle cramps, multiple chemical sensitivities, muscle pain, myofascial pain, mood swings, poor exercise tolerance, poor immunity, poor memory, recurrent skin rashes, brittle nails, hair loss, food allergies, constipation, diarrhea, liver dysfunction, brain fatigue, abdominal spasms, constant hunger pains, depleted appetite, irritable bowel syndrome, chemotherapy, food allergies, acne, liver dysfunction or inflammation of the bowel..
Nexira International

Luminate face mask

The present invention features novel cosmetic skin care compositions for improving the appearance of skin, particularly the reducing the appearance of age spots and discoloration.. .
Jan Marini Skin Research

Cartridges for the deposition of treatment compositions on keratinous surfaces

A micro electromechanical ink jet printing system that has a cartridge having a body that defines a core, and a die that contains one or more nozzles. There is a treatment composition contained within the cartridge core.
The Procter & Gamble Company

Methods for preparing a skin graft without culturing or use of biologics

The present invention generally relates to methods for preparing a skin graft without culturing or use of biologics. .
Kci Licensing, Inc.

Drive method and drive device of liquid crystal display

The present invention provides a drive method and a drive device of a liquid crystal display, and the drive method comprises: receiving an image to display; implementing skin color detection to the image pixels of the image to display to determine nude pixel and non skin color pixel; setting different skin color weights for the nude pixel and the non skin color pixel; implementing the color washout compensation to the image to display according to the skin color weight; driving the liquid crystal panel to show the image to display after the color washout compensation. With the aforesaid arrangement, the present invention preferably improves the resolution and viewing angle of the display at the same time..
Shenzhen China Star Optoelectronics Technology Co., Ltd.

Enforced unitasking in multitasking systems

A computer system includes one or more devices that are capable of multitasking (performing at least two tasks in parallel or substantially in parallel). In response to detecting that one of the devices is performing a first one of the tasks, the system prevents the devices from performing at least one of the tasks other than the first task (such as all of the tasks other than the first task).
Yagi Corp.

Polymeric substrates with immobilized antibodies and production thereof

The present invention relates to biofunctional polymeric substrates product comprising immobilized antibodies that selective bind to antigens namely autologous growth factors and an inflammatory molecule, uses and method of production. The bio-functional polymeric substrate can be used in a quantification method of antigens namely soluble growth factors, inflammatory molecules and hormones or the biofunctional polymeric substrate can be used to isolate extracellular vesicules.
Association For The Advancement Of Tissue Engineering And Cell Based Technology And Therapie

Phototherapy apparatus with interactive user interface

A phototherapy apparatus with interactive user interface for treating biological tissue of an animal or human target. The user interface comprises intuitive graphic menus which allow the clinicians or practitioners to define the properties of the biological tissue through easily observable physical characteristics such as weight, skin color, and hair color of the patient.
Bwt Property, Inc.

Methods for applying a skin treatment

The inventive subject matter provides kits, compositions and methods for treating or covering skin using a polymerizable formulation. The polymerizable formulation can include a first component including a siloxane polymer and a catalyst, and a second component including a siloxane polymer and a cross-linker.
Bio-silicote, Inc.

Methods for improving skin quality

A skin treatment regimen for delivery of a rinse-off personal skin care composition is provided. The rinse-off personal skin care composition includes varying ratios of a lathering agent to a hydrophobic benefit agent.
The Procter & Gamble Company

Diagnostic system for the detection of skin cancer

Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest.

Honeycomb structure comprising a cement skin composition with crystalline inorganic fibrous material

Disclosed is a honeycomb support structure comprising a honeycomb body and an outer layer or skin formed of a cement that includes an inorganic filler material having a first coefficient of thermal expansion from 25 c to 600 c and a crystalline inorganic fibrous material having a second coefficient of thermal expansion from 25 c to 600 c. Skin cement composition controls level of cement liquid/colloid components, for example water, colloidal silica, and methylcellulose migration into the substrate during the skin application process to form barrier to skin wetting and staining during the washcoating process..
Corning Incorporated

Agent for preventing or ameliorating vascular endothelial malfunction

An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved no production enhancing effect is provided. A no production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.
Kyowa Hakko Bio Co., Ltd.

Methods of treating dyskinesia and related disorders

The present disclosure describes compounds and pharmaceutically acceptable salts, thereof and compositions and formulations comprising the same that are useful in methods of treating dyskinesia or related disorders, and methods for treating dyskinesia or related disorders.. .
Melior Pharmaceuticals Ii, Llc

Topical compositions comprising hydroxy acids and cannabinoids for skin care

The present invention relates to compositions and methods for the prevention and treatment of skin disorders and for the rejuvenation of the skin. In particular, the application describes topical compositions and methods of treatments comprising the combined use of one or more cannabinoids and one or more hydroxy acids in a suitable carrier..
Kannainnovations Llc

Skin graft devices and methods

Devices and methods for obtaining a plurality of skin tissue particles for use in skin grafting.. .
Kci Licensing, Inc.

Detection of borders of benign and malignant lesions including melanoma and basal cell carcinoma using a geodesic active contour (gac) technique

A method for automatic segmentation of dermoscopy skin lesion images includes automating a geodesic active contour (gac) initialization to be sufficiently large to encompass the lesion yet lie near the actual lesion contour. In addition, a new image plane is found by transforming the original rgb image to a smoothed image that allows the gac to move without sticking on the minimum local energy.
Stoecker & Associates, Llc

Ammonia-oxidizing nitrosomonas eutropha strain d23

This disclosure provides, inter alia, an optimized strain of nitrosomonas eutropha (n. Eutropha) designated d23, d23-100, or aob d23-100.
Aobiome Llc

Novel pseudo ceramide compound, and pharmaceutical composition and cosmetic composition comprising same

The present invention relates to a pharmaceutical composition and a cosmetic composition, which contain, as an active ingredient, a novel pseudo compound having similar structural characteristics to natural ceramide 1, or a pharmaceutically acceptable salt or solvate thereof, and the composition containing the compound of the present invention as an active ingredient has an excellent effect of enhancing a skin barrier function, thereby exhibiting an effect of alleviating inflammatory skin diseases, and has an excellent skin barrier improving function and an excellent skin moisturization enhancing effect.. .
Neopharm Co., Ltd.

Quinoxaline derivatives as gpr6 modulators

That are gpr6 modulators and are therefore useful for the treatment of diseases treatable by modulation of gpr6, in particular treating parkinson disease, levodopa induced dyskinesias, huntington's disease, other dyskinesias, akinesias, and motor disorders involving dysfunction of the striatum, schizophrenia and drug addiction. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds..

Skin barrier function improving agent

[effect] the followings are found: a jak inhibitor increases the expression amounts of filaggrin, loricrin, involucrin and β-defensin 3 as skin barrier function-related proteins; a jak inhibitor significantly increases nmf production in a tape stripping-treated mouse; and a jak inhibitor significantly accelerates a reduction in tewl in a dry skin mouse model, namely improves the skin barrier function. The jak inhibitor can be used as an active ingredient of a therapeutic or preventive agent for skin diseases such as senile xerosis, asteatosis, eczema, contact dermatitis, ichthyosis vulgaris, netherton syndrome, type b peeling skin syndrome, etc..

Aza spiro alkane derivatives as inhibitors of metalloproteases

Enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of formula i and ii are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions..

2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof

Disclosed are heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. The compounds are useful for treating a mammal suffering from any one of a range of therapeutic indications, including alzheimer's disease, parkinson's disease, dyskinesias, tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, ganser's syndrome, migraine pain, bulimia, obesity, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, disorders of sleep, autism, mutism, trichotillomania, and hypothermia..
Duke University

Skin treatment formulations

Dermal treatment compositions include medium recovered from an adipose-derived stem cell culture where the medium is collected under defined conditions. The medium includes growth factors and other materials that, when transported to living portions of the skin, improve the condition of damaged or aged skin.

Skin lightening compositions

As defined herein.. .

Method and system for skin blemishes layered skin treatment

A system and method for performing layer treatment for skin blemish in which the target area of the skin is first treated by performing a deep layer treatment by cutting the fibrous bands and then performing a superficial skin treatment by using electromagnetic radiation and both of the treatment take place within the same day.. .

Implantable bone marrow access apparatus

Bone marrow access apparatus includes a bone attachment part attachable to bone, a tubular conduit part attached to the bone attachment part and defining a conduit communicating with a hollow interior of the bone attachment part, and a port attached to the conduit part. The port defines a hollow interior communicating with the conduit defined by the conduit part.

Mining social media for ultraviolet light exposure analysis

Social media databases are minded for data related to a subject person. The data in indicative of a level of ultraviolet light exposure of the subject person.
International Business Machines Corporation

Skeletal joint optimization for linear blend skinning deformations utilizing skeletal pose sampling

A novel and useful mechanism for the skinning of 3d meshes with reference to a skeleton utilizing statistical weight optimization techniques. The mechanism of the present invention comprises (1) an efficient high quality linear blend skinning (lbs) technique based on a set of skeleton deformations sampled from the manipulation space; (2) a joint placement algorithm to optimize the input skeleton; and (3) a set of tools for a user to interactively control the skinning process.
Technische Universiteit Delft

Linear blend skinning weight optimization utilizing skeletal pose sampling

A novel and useful mechanism for the skinning of 3d meshes with reference to a skeleton utilizing statistical weight optimization techniques. The mechanism of the present invention comprises (1) an efficient high quality linear blend skinning (lb s) technique based on a set of skeleton deformations sampled from the manipulation space; (2) a joint placement algorithm to optimize the input skeleton; and (3) a set of tools for a user to interactively control the skinning process.
Technische Universiteit Delft

Method and device for managing memory of user device

A method and a device dynamically managing background processes according to a memory status so as to efficiently use the memory in a user device supporting a multitasking operating system. The method includes determining reference information for adjustment of the number of background processes; identifying a memory status based on the reference information; and adjusting the number of the background processes in correspondence to the memory status..
Samsung Electronics Co., Ltd

A detecting an increased risk of developing skin cancer and a use of a genotype variant of the grhl3 gene

The present invention is directed to methods of identifying snp markers associated with skin cancers, and use of these markers to explain individual susceptibility to skin cancer development. In addition, described snps have been identified as potentially crucial for proper grhl3 protein function..
Instytut Biologii Doswaidczalnej Im. M. Nenckiego Polskiej Akademii Nauk

Optical treatment methods

A treatment system and method includes use of a chemical facilitator to provide a result-effective event against one or more negative therapeutic effects related to exposing to a light output a skin portion including a condition treatable in whole or in part with light. In one exemplary embodiment for skin treatment including tattoo removal, perfluorodecalin is used to inhibit or resolve whitening, for example to speed a laser therapy session..
On Light Sciences Inc.

Skin care composition

A skin care composition is described comprising water-soluble dye polymer comprising polymer backbone having negatively charged reactive dye substituent covalently bound thereto; and cosmetically acceptable carrier. The dye polymer is present in amount of 0.00001 to 0.1% in terms of reactive dye substituent by weight of the skin care composition.
Conopco, Inc., D/b/a Unilever

Biophotonic compositions and methods for providing biophotonic treatment

The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition.
Klox Technologies Inc.

Method and hosting a multitasking guest on a host system

Method for hosting a multitasking guest on a host system, wherein the guest is allocated a periodic execution server and a deferrable execution server associated with a partition of the system, event-driven tasks of the guest are assigned to the deferrable execution server, time-driven tasks of the guest are assigned to the periodic execution server, a hypervisor of the execution servers is assigned to a first priority group of the system, the deferrable execution server is assigned to a second priority group of the system, the periodic execution server is assigned to a third priority group of the system, and a preemptive task scheduler maintains a descending priority order among the priority groups while the execution servers execute the tasks concurrently.. .
Robert Bosch Gmbh

Human epithelial cell line for 3-d modelizing of cancer and treatment thereof

A cellular model is described that targets dysregulation or inappropriate activation of the sonic hedgehog/patched (shh/ptch) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, basal cell carcinoma (bcc) lesions..
Cnrs

Sodium channel blockers for skin disorders

Where r is defined herein.. .

Cosmetic compositions and uses thereof

Disclosed is a method for reducing the appearance of cellulite or improving the texture of skin in a target region of skin that has cellulite or rough skin texture, the method comprising topically applying a composition to the target region that includes an effective amount of a mixture of caffeine, escin, and an aqueous-alcoholic extract from ascophyllum nodosum, wherein topical application of the composition reduces the appearance of cellulite or improves the texture of the skin.. .
Mary Kay Inc.

Topical delivery of skin compositions having low ph

Low ph compositions for topical administration to skin are provided. They comprise a buffering agent having a pka of about 2.8 to about 4.2 and a cosmetically acceptable active ingredient having a pka within about 1 unit of the pka of the buffering agent.
Johnson & Johnson Consumer Inc.

Hesperidin-containing compositions and methods for treatment of skin disorders

Compositions and methods for treating aged skin or skin otherwise suffering from abnormal epidermal barrier function are disclosed, where the compositions include hesperidin.. .
The Regents Of The University Of California

Skinning for electronic vapor devices

A method is disclosed comprising displaying, by an electronic vapor device, a first image via one or more displays, determining, by the electronic vapor device, that the first image is to be changed, determining, by the electronic vapor device, a second image to display in place of the first image, and displaying, by the electronic vapor device, the second image via the one or more displays.. .
Lunatech, Llc

Automatic leg skinner

An automatic skinning assembly having a loading station, a first device, and a conveyor assembly extending between the first skinning device and the second skinning device.. .
Marel Meat Processing Inc.

Medical access ports, transfer devices and methods of use thereof

A medical system, comprising an implantable access port including an implantable access port body and at least one implantable access port needle; wherein the at least one needle is concealable inside the access port body in a concealed position and is exposable outside the access port body in an exposed position; wherein the at least one needle is arranged within the access port body to penetrate outwardly through skin of a subject from within the subject when the access port is implanted in the subject; a transfer device coupled to the at least one needle of the access port, the transfer device configured to transfer a fluid to and/or from the access port; and wherein the transfer device is configured to form a closed system with the access port, wherein the transfer device includes a fluid flow passage configured to transfer the fluid to and/or from the access port.. .
Versago Vascular Access, Inc.

Iontophoretic marking of the skin

Embodiments provide apparatus and methods for producing markings in the skin. One embodiment provides an apparatus for marking the skin comprising a housing and reservoir for storing a skin colorant.
Incube Labs, Llc

Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders

The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active agents for the treatment of human skin, especially in the treatment of acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, p. Acne bacteria associated disorders, and other superficial infections, including skin infections..
Foamix Pharmaceuticals Ltd.

Combination therapy for skin disorders

The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.. .
M. Alphabet 1, Llc

Use of nk-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with egfr-blocking drugs

The present disclosure provides methods for alleviating or preventing the negative physiological side effects associated with the administration of egfr blocking therapeutics. The disclosure provides, inter alia, methods for treating or preventing: hypomagnesemia, cardiac dysfunction, and skin lesions, which are induced by egfr blocking drugs, by administering an nk-1 receptor antagonist..
The George Washington University

Topical retinoid compositions

The present application relates to topical compositions. In particular, the present application relates to a topical composition comprising retinoid as active agent, and pharmaceutically acceptable excipient(s), and a process of preparing such compositions.
Dr. Reddy's Laboratories, Ltd.

Methods of treating developmental disorders with gaboxadol

Methods of treating developmental disorders such as angelman syndrome, fragile x syndrome, fragile x-associated tremor/ataxia syndrome (fxtas), autistic spectrum disorder, autism, asperger's syndrome, pervasive developmental disorder, childhood disintegrative disorder, rett syndrome, lanau-kleffner syndrome, prader-willi syndrome, tardive dyskinesia, and/or williams syndrome with gaboxadol or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder..
Ovid Therapeutics Inc.

Dissection handpiece and reducing the appearance of cellulite

A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
Ulthera, Inc.

Body illumination device

There is provided a body illumination device (100) adapted to surround at least a part of a user (102) comprising at least one inflatable structural element and a light emitter (120). The at least one inflatable structural element includes a first inflatable structural element (110).
Koninklijke Philips N.v.

Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation

The present invention provides a skin penetration-accelerating composition that eliminates the need for forming a drug into a particle structure and dramatically improves the skin penetration properties of a drug without breaking the skin tissue. The present invention also provides a preparation for transdermal administration containing the skin penetration-accelerating composition and a patch preparation containing the skin penetration-accelerating composition.
Nitto Denko Corporation

Pharmaceutical composition for preventing or treating skin cancer comprising panax spp. plant extract and preventing or treating skin cancer in a subject using the same

Provided are a pharmaceutical composition for preventing or treating skin cancer and a method of preventing or treating skin cancer in a subject by using the pharmaceutical composition, wherein the pharmaceutical composition includes a panax spp. Plant extract as an active ingredient..
Korea Institute Of Science And Technology

Electrically based medical treatment device and method

Embodiments of medical treatment including skin treatment using electrical energy, especially with the primary purpose for skin treatment for aesthetics are described generally herein. Other embodiments may be described and claimed..

Allergy skin test devices

An allergy skin test device can include a support strip having a top and bottom face. An allergen can be applied to an area of the bottom face forming an allergen portion.
Rememdia Lc

Benzoxazinone derivatives for treatment of skin diseases

The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (klk7), human kallikrein 5 (klk5), and human kallikrein 14 (klk14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, especially netherton syndrome..
Sixera Pharma Ab

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

Human lipoxygenases (loxs) are a family of iron-containing enzymes involved in catalyzing the oxidation of polyunsaturated fatty acids to provide the corresponding bioactive hydroxyeicosatetraenoic acid (hete) metabolites. These eicosanoid signaling molecules are involved in a number of physiologic responses such as platelet aggregation, inflammation, and cell proliferation.
Thomas Jefferson University

Kallikrein 7 inhibitors

The present invention relates to methods for inhibiting the activity of human kallikrein 7 (klk7) (also known as serine protease stratum corneum chymotryptic enzyme, scce). The invention further relates to the use of klk7 inhibitors of formula i for the treatment and prevention of diseases, more specifically for the treatment and prevention of skin diseases.
Sixera Pharma Ab

Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation

The present invention provides a skin penetration-accelerating composition that eliminates the need for forming a drug into a particle structure and dramatically improves the skin penetration properties of a drug without breaking the skin tissue. The present invention also provides a preparation for transdermal administration containing the skin penetration-accelerating composition and a patch preparation containing the skin penetration-accelerating composition.
Nitto Denko Corporation

Luminate eye gel

The present invention features novel cosmetic skin care compositions for improving the appearance of skin, particularly the periocular region.. .
Jan Marini Skin Research

Marking tissue surfaces for treatment of lesions by electrical nanopulses

This disclosure relates to an in vivo treatment of a skin lesion of a mammal comprising application of electrical energy to the skin lesion in a form of electrical pulses. At least one electrical pulse is applied.
Pulse Biosciences, Inc.

Compositions and methods for thermal skin treatment with metal nanoparticles

Treatment of skin tissue with photoactive materials and light, such as nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans. In particular, embodiments of thermal treatment of the skin surface with metal nanoparticles in surfactant containing solutions are disclosed..
Sienna Biopharmaceuticals, Inc.

Apparatus and methods for comprehensive ultrasound skin treatment

Cartridge apparatus (230) for use with a handle (220) is provided. The apparatus includes a housing (500) which: (a) includes a handle-coupling portion (235) shaped and sized to securely couple the housing to the handle and to facilitate separation of the housing from the handle, (b) shaped to define a skin-application portion (40) on an outer surface of the housing, and (c) includes at least one ultrasound element (60) in acoustic communication with the skin-application portion and configured to transmit ultrasound energy to the skin through the skin-application portion when the cartridge is attached to the handle.
Slender Medical Ltd.

Consumer goods product comprising lignin oligomer

(c) has a molar ratio of aromatic hydroxyl content to aliphatic hydroxyl content in the range of from 1.2 to 1.9, wherein the consumer goods product ingredient is an emulsifier, and wherein the lignin oligomer is in the form of an emulsion, and wherein the consumer goods product is selected from skin treatment composition, oral care treatment composition, and detergent composition.. .

Skin treatment apparatus utilising intense pulsed light (ipl)

The present invention relates to an apparatus for treating skin by means of intense pulsed light (ipl). Such apparatus may be used for the treatment of, for example, cosmetic purposes such as hair depilation or dermatological treatment of skin conditions such as acne or rosacea.
Ipulse Limited





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Skin for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Skin with additional patents listed. Browse our RSS directory or Search for other possible listings.


3.0395

file did exist - file did put12285

5 - 1 - 251